U.S., Feb. 18 -- An application to own the trademark for 'MAXION' has been filed on Oct. 07, 2024.
Owner(s):
Maxion Therapeutics Limited; C/O Mishcon de Reya,, , UNITED KINGDOM
Goods and/or Services:
For: Pharmaceuticals and pharmaceutical preparations for the treatment of diseases and conditions associated with dysregulation of ion channel and G-protein-coupled receptor activity, in particular, preparations for the prevention and treatment of pain, autoimmunity, cardiovascular disease and cancer; drugs, namely, pharmaceutical preparations for the treatment of diseases and conditions associated with dysregulation of ion channel and G-protein-coupled receptor activity, in particular, those for use in the prevention and treatment of pain,...